HemostOD

Based at the EPFL Innovation Park, HemostOD has developed an innovative solution for ex vivo on-demand production of blood platelets, thus providing an efficient alternative to blood donor platelet transfusions as known today. 
Support
2024 : Tech Growth
2022 : Tech Seed
Domain
Life sciences and health
Sub-domain
LabTech & Diagnosis
School
CHUV, EPFL, UNIGE , UNIL
EPFL Innovation Park
Renens / Vaud